| Treatment-Refractory Dravet Syndrome: Considerations for Novel Medications | | 2022 |
| Label accuracy of unregulated cannabidiol (CBD) products: measured concentration vs. label claim | Journal of Cannabis Research | 2022 |
| Management of Toxicological Emergencies in the School Setting: An Overview for School Nurses Part 2 | NASN School Nurse (Print) | |
| Recent advances in drug delivery to the central nervous system by inhalation. | Expert Opinion on Drug Delivery | 2022 |
| The Effects of Cannabinoids on Sleep. | Journal of Primary Care and Community Health | 2022 |
| Data_Sheet_1.docx | | 2020 |
| Evaluation of the impact of a clinical pharmacist on a specialty neurology clinic's adherence to recommended laboratory test monitoring | Journal of Managed Care & Specialty Pharmacy | 2021 |
| Cannabis in Palliative Medicine | | 2020 |
| Cannabinoids and Mental Health, Part 2: The Search for Clinical Applications | Journal of Psychosocial Nursing and Mental Health Services | 2019 |
| Post Marketing Safety of Plus CBD™ Products, a Full Spectrum Hemp Extract: A 2-Year Experience | Journal of Dietary Supplements | 2020 |
| Expanding the Treatment Landscape for Lennox-Gastaut Syndrome: Current and Future Strategies | CNS Drugs | 2021 |
| Screening and confirmation methods for the qualitative identification of nine phytocannabinoids in urine by LC-MS/MS | Clinical Biochemistry | 2021 |
| A Review of the Selected and Newer Antiseizure Medications Used in Childhood Epilepsies | Indian Journal of Pediatrics | 2021 |
| Novel cannabidiol aspartame combination treatment (JW-100) significantly reduces ISGA score in atopic dermatitis: Results from a randomized double-blinded placebo-controlled interventional study | Journal of Cosmetic Dermatology | 2021 |
| Impact of pre-operative recreational marijuana use on outcomes two years after orthopaedic surgery | International Orthopaedics | 2021 |
| Highly Purified Cannabidiol for Epilepsy Treatment: A Systematic Review of Epileptic Conditions Beyond Dravet Syndrome and Lennox-Gastaut Syndrome | CNS Drugs | 2021 |
| Cannabidiol in conjunction with clobazam: analysis of four randomized controlled trials | Acta Neurologica Scandinavica | 2021 |
| Practical use of pharmaceutically purified oral cannabidiol in Dravet syndrome and Lennox-Gastaut syndrome | Expert Review of Neurotherapeutics | 2021 |
| Use of Herbal Medicine by Pregnant Women: What Physicians Need to Know | Frontiers in Pharmacology | 2019 |
| Disposition of Oral Cannabidiol-Rich Cannabis Extracts in Children with Epilepsy | Clinical Pharmacokinetics | 2020 |
| A Review of Scientific Evidence for THC:CBD Oromucosal Spray (Nabiximols) in the Management of Chronic Pain | Journal of Pain Research | 2020 |
| Thrombocytopenia in pediatric patients on concurrent cannabidiol and valproic acid | Epilepsia | 2020 |
| Cutaneous Adverse Events in Newly Approved FDA Non-cancer Drugs: A Systematic Review | Drugs in R and D | 2020 |
| Critical Aspects Affecting Cannabidiol Oral Bioavailability and Metabolic Elimination, and Related Clinical Implications | CNS Drugs | 2020 |
| Does cannabidiol have antiseizure activity independent of its interactions with clobazam? An appraisal of the evidence from randomized controlled trials | Epilepsia | 2020 |
| The effect of cannabidiol on the pharmacokinetics of carbamazepine in rats | Naunyn-Schmiedeberg's Archives of Pharmacology | 2020 |
| Safety Considerations in Cannabinoid-Based Medicine | International Journal of General Medicine | 2020 |
| Therapeutic advances in Dravet syndrome: a targeted literature review | Expert Review of Neurotherapeutics | 2020 |
| Beyond Green Chemistry: Teaching Social Justice in Organic Chemistry | Journal of Chemical Education | 2020 |
| A pediatric patient with autism spectrum disorder and epilepsy using cannabinoid extracts as complementary therapy: a case report | Journal of Medical Case Reports | 2020 |
| The Essential Medicinal Chemistry of Cannabidiol (CBD) | Journal of Medicinal Chemistry | 2020 |
| Report of a 6-month-old Asian infant with early infantile epileptic encephalopathy whose seizures were eliminated by cannabidiol | Epilepsy and Behavior Reports | 2020 |
| Slow Titration of Cannabidiol Add-On in Drug-Resistant Epilepsies Can Improve Safety With Maintained Efficacy in an Open-Label Study | Frontiers in Neurology | 2020 |
| Reduction in Tamoxifen Metabolites Endoxifen and N-desmethyltamoxifen With Chronic Administration of Low Dose Cannabidiol: A CYP3A4 and CYP2D6 Drug Interaction | Journal of Pharmacy Practice | 2020 |
| Cannabidiol in the Treatment of Epilepsy: A Focused Review of Evidence and Gaps | Frontiers in Neurology | 2020 |
| Buprenorphine-cannabis interaction in patients undergoing opioid maintenance therapy | European Archives of Psychiatry and Clinical Neuroscience | 2021 |
| Indications and administration practices amongst medical cannabis healthcare providers: a cross-sectional survey | BMC Family Practice | 2019 |
| Medicinal use of cannabis based products and cannabinoids | BMJ, The | 2019 |
| A Phase 1, Open-Label, Parallel-Group, Single-Dose Trial of the Pharmacokinetics and Safety of Cannabidiol (CBD) in Subjects With Mild to Severe Hepatic Impairment | Journal of Clinical Pharmacology | 2019 |
| An Update of Current Cannabis-Based Pharmaceuticals in Pain Medicine | Pain and Therapy | 2019 |
| Cannabidiol as a Novel Candidate Alcohol Use Disorder Pharmacotherapy: A Systematic Review | Alcoholism: Clinical and Experimental Research | 2019 |
| [Cannabis-derived medicines for the treatment of chronic pain : Problems resulting from medical appraisals in the experience of the Medical Advisory Board of the Statutory Health Insurance Funds North] | Schmerz | 2019 |
| Stiripentol: A Review in Dravet Syndrome | Drugs | 2019 |
| [Survey of neurologists regarding their attitudes toward medicinal cannabis and the effects of evidence-based cannabis education] | Clinical Neurology | 2019 |
| Cannabis and Cannabinoids: Kinetics and Interactions | American Journal of Medicine | 2019 |
| Everolimus as adjunctive therapy for tuberous sclerosis complex-associated partial-onset seizures | Expert Review of Neurotherapeutics | 2019 |
| Efficacy and Safety of Cannabidiol in Epilepsy: A Systematic Review and Meta-Analysis | Drugs | 2018 |
